Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis

H Florez, J Hernández-Rodríguez, A Muxi… - …, 2020 - academic.oup.com
Objective To analyse the clinical utility of trabecular bone score (TBS) evaluation for fracture
risk assessment in glucocorticoid (GC)-treated patients compared with BMD assessment …

Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis.

H Florez, J Hernández-Rodríguez, A Muxi… - Rheumatology …, 2020 - europepmc.org
OBJECTIVE: To analyse the clinical utility of trabecular bone score (TBS) evaluation for
fracture risk assessment in glucocorticoid (GC)-treated patients compared with BMD …

Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis.

H Florez, J Hernández-Rodríguez, A Muxi… - …, 2020 - search.ebscohost.com
Objective To analyse the clinical utility of trabecular bone score (TBS) evaluation for fracture
risk assessment in glucocorticoid (GC)-treated patients compared with BMD assessment …

Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis

H Florez, J Hernández-Rodríguez… - Rheumatology …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective To analyse the clinical utility of trabecular bone score (TBS) evaluation for fracture
risk assessment in glucocorticoid (GC)-treated patients compared with BMD assessment …

Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis

H Florez, J Hernández-Rodríguez, A Muxi, JL Carrasco… - Rheumatology, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Objective</jats: title>< jats: p> To
analyse the clinical utility of trabecular bone score (TBS) evaluation for fracture risk …

Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis

H Florez, J Hernández-Rodríguez, A Muxi… - …, 2020 - academic.oup.com
Objective To analyse the clinical utility of trabecular bone score (TBS) evaluation for fracture
risk assessment in glucocorticoid (GC)-treated patients compared with BMD assessment …